Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
103.87
-4.10 (-3.80%)
Feb 5, 2026, 4:00 PM EST - Market closed
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $6.93 billion as of February 6, 2026. Its market cap has increased by 96.09% in one year.
Market Cap
6.93B
Enterprise Value
6.63B
1-Year Change
96.09%
Ranking
Category
Stock Price
$103.87
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $6.93B, an increase of 751.69%. That is a compound annual growth rate of 29.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 7.21B | 0.87% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 8.73B |
| Praxis Precision Medicines | 8.41B |
| Nuvalent | 8.15B |
| Vaxcyte | 7.94B |
| Krystal Biotech | 7.80B |
| Cytokinetics | 7.77B |
| Belite Bio | 6.86B |
| Mirum Pharmaceuticals | 6.23B |